Imvax Company
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Total Funding:
166694660
Last Funding Type:
Series C
Estimated Revenue:
Less than $1M
Founded Date:
2015-01-01
Industry:
Whole-Cell Antigens
Employee Number:
11-50
Last Funding Date:
2020-07-16
Funding Status:
Late Stage Venture
Headquarters:
Philadelphia, Pennsylvania, United States
Investors Number:
6